UK Markets closed

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,770.20-16.00 (-0.90%)
At close: 04:45PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 31,817.00
52-week low 31,215.83
50-day moving average 31,693.52
200-day moving average 31,570.93

Share statistics

Avg vol (3-month) 310.65M
Avg vol (10-day) 311.41M
Shares outstanding 55.03B
Implied shares outstanding 6N/A
Float 84.92B
% held by insiders 10.79%
% held by institutions 147.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.75
Forward annual dividend yield 44.27%
Trailing annual dividend rate 30.80
Trailing annual dividend yield 30.04%
5-year average dividend yield 45.31
Payout ratio 479.29%
Dividend date 3N/A
Ex-dividend date 419 May 2022
Last split factor 22:1
Last split date 328 Oct 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 14.02%
Operating margin (ttm)23.40%

Management effectiveness

Return on assets (ttm)6.36%
Return on equity (ttm)27.51%

Income statement

Revenue (ttm)36.48B
Revenue per share (ttm)7.28
Quarterly revenue growth (yoy)31.80%
Gross profit (ttm)22.66B
EBITDA 10.82B
Net income avi to common (ttm)5.11B
Diluted EPS (ttm)85.30
Quarterly earnings growth (yoy)67.90%

Balance sheet

Total cash (mrq)13.98B
Total cash per share (mrq)2.78
Total debt (mrq)33.35B
Total debt/equity (mrq)147.36
Current ratio (mrq)1.19
Book value per share (mrq)3.08

Cash flow statement

Operating cash flow (ttm)10.16B
Levered free cash flow (ttm)7.01B